TrialClinical journal of the American Society of Nephrology : CJASN2016

Effect of Tolvaptan in Autosomal Dominant Polycystic Kidney Disease by CKD Stage: Results from the TEMPO 3:4 Trial.

Vicente E Torres et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.